Delivery Order SPE2DX22D0019-SPE2D826FCS26
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $370,070.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 22, 2026, with completion scheduled for January 23, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $67,062.52 by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with a completion deadline of January 13, 2026. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,982.40 on January 20, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 21, 2026, and carries no set-aside designation. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,059.87 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This firm fixed-price contract (4570352489) was competitively awarded without set-aside designation and is scheduled for completion by December 24, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,576.80 by the Defense Logistics Agency's Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,892.39 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). The order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,237.52 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $22,542.24 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by November 4, 2025. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,815.06 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, which carries an ultimate completion date of January 20, 2026, represents a child contract under the parent organization Cencora, Inc. (doing business as AmerisourceBergen). The award was made on a competitive, non-set-aside basis and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCS26Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $22,535.80 by the Defense Logistics Agency's Medical Supply Chain on January 26, 2026. This contract represents a firm fixed-price delivery order with an ultimate completion date of January 27, 2026, and was competitively awarded without a set-aside designation. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order exemplifies AmerisourceBergen's role as a critical federal medical procurement vendor, supplying prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), the company maintains a significant presence in federal pharmaceutical distribution through competitive contract awards that demonstrate its capability to efficiently fulfill essential medical supply requirements for military treatment facilities and federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 1/25/26 |